Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma

NCT06113081 · clinicaltrials.gov ↗
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Fondazione Italiana Linfomi - ETS